Product Information

FLUVOXAMINE ER 100 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $3.5119 per EA under NDC 69452018213. Its NADAC has been published 119 times since Aug 14, 2024.

FDA first approved this application on May 11, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUVOXAMINE ER 100 MG CAPSULE

Fluvoxamine Maleate
$3.5119per EA

Strength

100 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452018213

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FLUVOXAMINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212182

FDA Approved

5/11/2020

TE Code

AB

On Market Since

12/1/2020

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for FLUVOXAMINE ER 100 MG CAPSULE has been published 119 times since Aug 14, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$3.5119 per EA
All-time high$5.9719 (Nov 13, 2024)
All-time low$3.5057 (Aug 14, 2024)
52-week high$5.1958
52-week low$3.5119
Median price$5.1193
Average price$5.0224
Largest weekly change+31.6% (Sep 18, 2024)
Weeks tracked119
Tracking sinceAug 14, 2024

Price History

1W

-4.1%

1M

-13.9%

3M

-22.4%

6M

-30.1%

1Y

-25.9%

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FLUVOXAMINE ER 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 100 MG CAPSULE, manufactured by Bionpharma Inc., is $3.5119 per EA (NDC 69452018213), effective Nov 18, 2026.

How has the price of FLUVOXAMINE ER 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FLUVOXAMINE ER 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 119 weekly CMS publications since Aug 14, 2024.

What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 100 MG CAPSULE?

Since Aug 14, 2024, the NADAC for FLUVOXAMINE ER 100 MG CAPSULE has ranged from a low of $3.5057 (Aug 14, 2024) to a high of $5.9719 (Nov 13, 2024), with a median of $5.1193 per EA.

Are there cheaper alternatives to FLUVOXAMINE ER 100 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE ER 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures FLUVOXAMINE ER 100 MG CAPSULE?

FLUVOXAMINE ER 100 MG CAPSULE (NDC 69452018213) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.